MNMD — Mind Medicine (MindMed) Income Statement
0.000.00%
Last trade - 00:00- $1.04bn
- $896.80m
- 32
- 16
- 60
- 27
Annual income statement for Mind Medicine (MindMed), fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 33 | 93.9 | 66.3 | 93.9 | 101 |
| Operating Profit | -33 | -93.9 | -66.3 | -93.9 | -101 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -33.9 | -94.2 | -56.8 | -95.7 | -109 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -33.9 | -93 | -56.8 | -95.7 | -109 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -33.9 | -93 | -56.8 | -95.7 | -109 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -33.9 | -93 | -56.8 | -95.7 | -109 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.91 | -3.4 | -1.84 | -2.44 | -1.58 |